- We will not stop working until the day
that we are recognized as a global pharmaceutical company leading
the improvement medicine research.

  • 2018

    Change company name to Pharma Research BIO

    Disposal of division about GBIO

    Obtain a government permission to manufacture medicines at Bio Plant in Gangneung

    Request for approval of export items by Botulinum Toxins

    Completed GMP inspection for The Ministry of Food and Drug Safety.

  • 2017

    Completed construction of Plant only for Botulinum toxin

    Plant only for Botulinum toxin reported BSL2

    IND submission for Botulinum Toxin

  • 2016

    Plant acquisition and remodeling in Gangneung(Botulinum Toxin Only)

  • 2015

    Certified by the Corporate Capital Research Institute

    Opening of R&D center in Gangneung

    Report on R&D Center BSL2

    listed on the KONEX

  • 2010

    Engagement of consulting contract for EPO, hepatitis B vaccine, recombinant protein, and Multiple Sclerosis treatment

  • 2009

    Founding BIOCND Co., Ltd.

    Commencing the biopharmaceutical development consulting business


  • 파마리서치바이오

    KR CI

  • 파마리서치바이오

    EN CI

Contact Us

Head office and factory

641-3, Saimdang-ro, Gangneung-si, Gangwon-do
TEL: +82-33-655-7560, FAX: +82-33-655-7564

Research Center

62, Pangyo-ro 255beon-gil, Bundang-gu,
Seongnam-si, Gyeonggi-do, Korea,
TEL: +82-31-8039-1411